For TNBC, CD20-low, CD8-high identified a statistically significant poor prognostic group, with double-low status not quite significant.
← all excerpts
TILs Immunophenotype in Breast Cancer Predicts Local Failure and Overall Survival: Analysis in a Large Radiotherapy Trial with Long-Term Follow-Up.
1
—
—